U.S. 3d Printed Drugs Market Size & Outlook, 2023-2030

The 3d printed drugs market in the United States is expected to reach a projected revenue of US$ 93.6 million by 2030. A compound annual growth rate of 15.4% is expected of the United States 3d printed drugs market from 2024 to 2030.
Revenue, 2023 (US$M)
$34.3
Forecast, 2030 (US$M)
$93.6
CAGR, 2024 - 2030
15.4%
Report Coverage
U.S.

U.S. 3d printed drugs market highlights

  • The U.S. 3d printed drugs market generated a revenue of USD 34.3 million in 2023 and is expected to reach USD 93.6 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 15.4% from 2024 to 2030.
  • In terms of segment, neurology was the largest revenue generating application in 2023.
  • Orthopedic is the most lucrative application segment registering the fastest growth during the forecast period.


3d printed drugs market data book summary

Market revenue in 2023USD 34.3 million
Market revenue in 2030USD 93.6 million
Growth rate15.4% (CAGR from 2023 to 2030)
Largest segmentNeurology
Fastest growing segmentOrthopedic
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDental, Orthopedic, Neurology
Key market players worldwideGlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals


Other key industry trends

  • In terms of revenue, U.S. accounted for 33.4% of the global 3d printed drugs market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. 3d printed drugs market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 93.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

3D Printed Drugs Market Scope

3d printed drugs market segmentation & scope
Medical Implants
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Prosthetics
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Wearable Devices
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Tissue Engineering
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Medical
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Biosensors
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Consumer/Personal Product Testing
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Bioinks
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Food and Animal Product
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing

3D Printed Drugs Market Companies

Name Profile # Employees HQ Website

U.S. 3d printed drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.


Neurology was the largest segment with a revenue share of 50.73% in 2023. Horizon Databook has segmented the U.S. 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.


Major factors contributing to market growth include the increasing geriatric population, strong government support for quality healthcare, supportive reimbursement policies in the U.S., and several leading players in the country. For instance, FABRX LTD., a medical technology company, is one of the world’s major providers of 3D printed drugs for healthcare providers. In addition, the company is involved in the launch of products, contributing to market growth.


For instance, in 2020, FABRX Ltd. launched the first pharmaceutical 3D printer, the M3DIMAKER system, to produce personalized medicine. The printer is designed to produce customized 3D printed tablets called Printlets. In addition, universities and research institutions are undertaking strategic initiatives to foster market growth.


For instance, in February 2020, Aprecia Pharmaceuticals, LLC. partnered with Purdue University’s College of Pharmacy to advance the science and technology of 3D printed pharmaceuticals. This extensive collaboration focused on developing future equipment and medications in the 3D printed pharmaceutical domain.

Reasons to subscribe to U.S. 3d printed drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. 3d printed drugs market databook

  • Our clientele includes a mix of 3d printed drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into U.S. 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. 3d printed drugs market size, by application, 2018-2030 (US$M)

U.S. 3D Printed Drugs Market Outlook Share, 2023 & 2030 (US$M)

U.S. 3d printed drugs market size, by application, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more